International Flavors & Fragrances Inc (IFF)
Fair bewertetFundamental
51
Kurs
$83.48
Marktkapitalisierung
$21.88B
Teil 1 · Was das Unternehmen wert ist
Übersicht
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18. September 2026 with claude-haiku-4-5 — shared with all users
The world's largest flavour and fragrance house, competing with IFF for the same consumer-goods customers across taste, scent and active beauty ingredients.
Born from the Firmenich–DSM merger, it sells perfumery, taste and nutrition ingredients to the same food, beverage and personal-care brands IFF serves.
German flavour-and-fragrance group bidding for the same fragrance, flavour and cosmetic-ingredient contracts with global FMCG customers.
Competes head-on in taste and nutrition systems for food and beverage manufacturers, the segment where IFF places its Nourish business.
Rivals IFF's Health & Biosciences arm in enzymes, cultures and probiotics sold to the same food, beverage and household-care producers.
US specialty ingredients maker competing for the same flavour and colour supply contracts with food, beverage and personal-care brands.
Bilanz & Liquidität
Umsatz
$10.82B
Letzte 12 Monate (bis 30.6.2026)
Nettogewinn
$279M
Letzte 12 Monate (bis 30.6.2026)
Freier Cashflow
$256M
Gesamtes Eigenkapital
$14.15B
Gesamtverbindlichkeiten
$11.35B
Current Ratio
2.06
Zinsdeckungsgrad
4.33
Schulden/EBITDA
10.71
Gewinn je Aktie
Umsatz & Nettogewinn
Freier Cashflow
Ertragsaufschlüsselung
Historische Aufstellung
Margen im Zeitverlauf
Verschuldung im Zeitverlauf
Wie schwer die Schulden wiegen
Wachstumsraster
Wachstum — Umsatz
Innerer-Wert-Schätzung
Innerer Wert
$90.73
Aktueller Kurs
$83.48
Sicherheitsmarge
+8.0%
Innerer-Wert-Spanne
$58.98 - $122.49
Streubreite zwischen den verwendeten Bewertungsmethoden, kein statistisch kalibriertes Konfidenzintervall.
Bewertungsmethoden
Bewertungskennzahlen
P/E-Verhältnis
75.89
ROE
-2.5%
P/B-Verhältnis
1.52
P/FCF
39.44
Bruttomarge
36.5%
ROIC
3.1%
Rentabilitäts-Radar
Wertschöpfung (Wettbewerbsvorteil)
ROIC
3.1%
WACC
8.0%
ROIC − WACC
-4.9 pp
Der ROIC liegt unter den Kapitalkosten: Das Unternehmen vernichtet für jeden investierten Dollar Wert.
Fundamentalanalyse-Kriterien
Bestanden (12)
- Gross Margin 36.5%
- P/B Ratio 1.52
- Debt/Equity ratio
- Operating Margin 7.5%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Revenue Growth 5Y 16.5%
- Analyst Consensus 72% Buy
- Earnings Quality (OCF/NI) 4.16
- Share Dilution -0.8%
- Piotroski F-Score 6/9
Nicht bestanden (12)
- EPS shows upward trend
- Price CAGR -3.37%
- ROIC 3.1%
- P/FCF 39.44
- CapEx intensity
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- ROE 2.1%
- Earnings Surprise avg -3.4%
Nicht verfügbar (3)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
- Net Margin Trend (invalid data)
Piotroski F-Score
Gemischte Signale: Einige Bereiche bedürfen Aufmerksamkeit
Gewinnqualität
Hohe Qualität: Gewinne durch Cashflow gedeckt
Aktienverwässerung
Aktienrückkäufe. Aktionärsfreundlich
Institutionelle Beteiligungen
Unternehmensführung
Führungsteam
| Name | Position | Alter |
|---|---|---|
| Mr. Jon Erik Fyrwald | CEO & Director | 66 |
| Mr. Michael DeVeau | Executive VP & CFO | 44 |
| Mr. Yuvraj Arora | President of Taste Division & Chief Commercial Officer | 53 |
| Mr. Andres Muller | President of Food Ingredients | 60 |
| Ms. Leticia Goncalves Lourenco | President of Health & Biosciences | 50 |
| Mr. Ralf Finzel Ph.D. | Executive VP & Global Operations Officer | 61 |
| Mr. Marc H. Birenkrant | Controller & Chief Accounting Officer | 52 |
| Mr. Vivek Verma | Executive VP & Chief Information Officer | 56 |
| Mr. Stephen N. Landsman Esq., J.D. | Executive VP & General Counsel | 66 |
| Ms. Deborah Borg | EVP & Chief People and Culture Officer | 48 |
Prüfungsrisiko
5
Vorstandsrisiko
1
Vergütungsrisiko
9
Aktionärsrechterisiko
6
Teil 2 · Der Preis und der Einstiegszeitpunkt
Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.
Dokumente
- Dokument ansehen
Jahresbericht (10-K)
Ein jährlicher Überblick über das Geschäft, die Finanzergebnisse und die Risiken des Unternehmens.
Eingereicht am 2026-02-27
- Dokument ansehen
Quartalsbericht (10-Q)
Ein Update zur finanziellen Entwicklung der letzten drei Monate.
Eingereicht am 2026-08-04
- Dokument ansehen
Ad-hoc-Meldung (8-K)
Eine Mitteilung über ein wichtiges Ereignis, etwa einen Führungswechsel oder eine bedeutende Ankündigung.
Eingereicht am 2026-08-04
via SEC EDGAR
Ertragshistorie
via SEC EDGAR
Latest News
Recent headlines for IFF, sourced from Markets Gazette.